Skip to main content
. 2020 Mar 17;27(6):610–619. doi: 10.1111/jvh.13272

Figure 4.

Figure 4

A, HBV RNA detectability according to HBsAg loss at the end of follow‐up. Bars represent the proportion of patients with detectable or undetectable HBV RNA levels according to HBsAg loss at the end of follow‐up. B, Univariable diagnostic accuracy of early on‐treatment HBV RNA for the prediction of HBeAg loss at the end of follow‐up. Bars represent the area under the curve (AUC) for HBV RNA at baseline, week 12 and week 24 for the prediction of HBeAg loss at the end of follow‐up. Because of the low number of patients with HBsAg loss, multivariable regression analysis could not be performed for this end point